Oct. 27 at 10:02 PM
$CRVS MC 550, conservatively, after more data comes out
$5B valuation is reasonable. That puts it at 70-80 per share. This might be the next VRNA kinda stock. It can easily be more than 70-80, but let’s not get too excited, let the data come and dictate the stock price.